leisure time -WSS

leisure time

author：hotspot 2025-08-26 10:54:57 - browse：83

WICHITA, Kan. -- The Kansas bar where nine people were wounded by gunfire last month has permanently closed.

An attorney for City Nightz told the Wichita Eagle that the club owner felt he had no choice but to close because of all the negative publicity and because police blaming the bar for the shooting.

“The city has basically made it so burdensome to stay open, they can’t stay open,” attorney Charley O’Hara said. “He feels like he was singled out and blamed for a lot of things that happen all over the city and they don’t blame other people.”

The city suspended City Nightz's liquor license for 30 days after the shooting, and the year-old club never reopened.

Nine people were shot July 2 and two others trampled in the chaos afterward. No one died. Police have said that the seven men and two women who were shot ranged in age from 22 to 34.

Several people have been arrested. A St. Louis-area man was arrested July 3, but prosecutors later determined he fired his gun to defend himself after shots were fired by others.

Wichita is a city of nearly 400,000 people, about 200 miles (320 kilometers) southwest of Kansas City, Missouri.

Previous article： Peter Hotez and the public health issue of online harassment
Next article： ASCO eve: Let’s set the table for this year's meeting

WSS

Will the IRA bring competition to the biologics market?

FDA panel endorses Alnylam’s heart drug — after picking it apart

Generate Biomedicines machine learning biotech raises $273M

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

FDA panel endorses Alnylam’s heart drug — after picking it apart

WATCH: Why do bright lights make us see spots?

focus

leisure time

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Reports of telehealth's death have been greatly exaggerated

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA panel endorses Alnylam’s heart drug — after picking it apart

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How medical schools plan to diversify without affirmative action

hotspot

What to make of Biden’s latest efforts on cancer research

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Popular nasal decongestant doesn't actually relieve congestion

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Study finds gene variants tied to breast cancer risk in Black women

What to make of Biden’s latest efforts on cancer research

Wikipedia

explore

leisure time

focus